Delivery Order SPE2DB20D7066-SPE2DB24FC2BY
Award Date 4/26/24
Potential Completion Date 4/29/24
Potential Value $109K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The contract, valued at $5,927.58, is a firm-fixed-price delivery order with a completion date of September 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,340.78, is a delivery order for Biktarvy 50-200-25 mg tablet with an ultimate completion date of March 1, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $37,387.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty medication, over a term ending on January 11, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $82,631.52. The contract has an ultimate completion date of April 28, 2023 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award, with a ceiling value of $15,779.74, is for the delivery of the medication Biktarvy 50-200-25 MG Tablet, a pharmaceutical product used in the treatment of HIV. The contract has an ultimate completion date of May 10, 2024. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $184,789.80 firm fixed-price delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $72,594.31, is for the delivery of Biktarvy 50-200-25 mg tablets. This is a firm fixed-price delivery order contract with a completion date of December 7, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract, valued at $26,281.51, is for the delivery of Biktarvy 50-200-25 mg tablets and has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $74,541.51, is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Biktarvy 50-200-25 mg tablet in 30-count packages to the Defense Logistics Agency (DLA). The contract, valued at $92,775.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...